BridgeBio Pharma, Inc. (BBIO) Covered Calls

You can sell covered calls on BridgeBio Pharma, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for BBIO (prices last updated Fri 4:16 PM ET):

BridgeBio Pharma, Inc. (BBIO) Stock Quote
Last	Change	Bid	Ask	Volume	P/E	Market Cap
23.72	-0.39	23.75	23.88	2.7M	-	4.6

Covered Calls For BridgeBio Pharma, Inc. (BBIO)
Expiration	Strike	Call Bid	Net Debit	Return If Flat	Annualized Return If Flat
Dec 20	22.5	4.10	19.78	13.8%	140%
Jan 17	22.5	4.50	19.38	16.1%	91.8%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls? Sign Up For A Free Trial

Extended Business Description

BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 20 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include BBP-265, an oral small molecule transthyretin (TTR), which is ongoing Phase 3 clinical trial for the treatment of TTR amyloidosis, including cardiomyopathy and polyneuropathy manifestations; infigratinib, an oral FGFR1-3 selective tyrosine kinase inhibitor for the treatment of FGFR-driven cancers and achondroplasia; BBP-631, a preclinical adeno-associated virus gene transfer product candidate for the treatment of congenital adrenal hyperplasia caused by 21OHD; and BBP-454, a preclinical development program for small molecule inhibitors of KRAS for the treatment of pan-mutant KRAS-driven cancers. The company also engages in developing products for Mendelian, genetic dermatology, oncology, and gene therapy diseases. BridgeBio Pharma, Inc. has license agreements with the Leland Stanford Junior University, The Regents of the University of California, and Leidos Biomedical Research, Inc.; strategic collaboration agreements with Johns Hopkins University and University of Florida; University of Colorado Anschutz Medical Campus; Salk Institute for Biological Studies; Maze Therapeutics; and UC San Francisco. The company was founded in 2015 and is headquartered in Palo Alto, California.

Top 10 Open Interest For Dec 20 Expiration				Top 5 High Yield
1.	NVDA covered calls	6.	QQQ covered calls	1.	SAVA covered calls
2.	SPY covered calls	7.	XLF covered calls	2.	RKLB covered calls
3.	EEM covered calls	8.	KWEB covered calls	3.	LUNR covered calls
4.	FXI covered calls	9.	TLT covered calls	4.	NMRA covered calls
5.	IWM covered calls	10.	KRE covered calls	5.	CRVS covered calls

Want more examples? BBH Covered Calls | BBMC Covered Calls